Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - Results from a nationwide clinical audit

István Kiss, Zoltán Kiss, Csaba Ambrus, András Szabó, János Szegedi, József Balla, Erzsébet Ladányi, Botond Csiky, Ottó Árkossy, Marietta Török, Sándor Túri, Imre Kulcsár

Research output: Contribution to journalArticle

8 Citations (Scopus)


Background: Achieving target levels of laboratory parameters of bone and mineral metabolism in chronic kidney disease (CKD) patients is important but also difficult in those living with end-stage kidney disease. This study aimed to determine if there are age-related differences in chronic kidney disease-mineral and bone disorder (CKD-MBD) characteristics, including treatment practice in Hungarian dialysis patients. Methods. Data were collected retrospectively from a large cohort of dialysis patients in Hungary. Patients on hemodialysis and peritoneal dialysis were also included. The enrolled patients were allocated into two groups based on their age (<65 years and ≥65 years). Characteristics of the age groups and differences in disease-related (epidemiology, laboratory, and treatment practice) parameters between the groups were analyzed. Results: A total of 5008 patients were included in the analysis and the mean age was 63.4±14.2 years. A total of 47.2% of patients were women, 32.8% had diabetes, and 11.4% were on peritoneal dialysis. Diabetes (37.9% vs 27.3%), bone disease (42.9% vs 34.1%), and soft tissue calcification (56.3% vs 44.7%) were more prevalent in the older group than the younger group (p<0.001 for all). We found an inverse relationship between age and parathyroid hormone (PTH) levels (p<0.001). Serum PTH levels were lower in patients with diabetes compared with those without diabetes below 80 years (p<0.001). Diabetes and age were independently associated with serum PTH levels (interaction: diabetes × age groups, p=0.138). Older patients were more likely than younger patients to achieve laboratory target ranges for each parameter (Ca: 66.9% vs 62.1%, p<0.001; PO§ssub§4§esub§: 52.6% vs 49.2%, p<0.05; and PTH: 50.6% vs 46.6%, p<0.01), and for combined parameters (19.8% vs 15.8%, p<0.001). Older patients were less likely to receive related medication than younger patients (66.9% vs 79.7%, p<0.001). Conclusions: The achievement of laboratory target ranges for bone and mineral metabolism and clinical practice in CKD depends on the age of the patients. A greater proportion of older patients met target criteria and received less medication compared with younger patients.

Original languageEnglish
Article number155
JournalBMC Nephrology
Issue number1
Publication statusPublished - Jul 22 2013


  • Calcium (Ca)
  • Chronic kidney disease (CKD)
  • Chronic kidney disease-mineral and bone disorder (CKD-MBD)
  • End-stage renal disease (ESRD)
  • Parathyroid hormone (PTH)
  • Phosphate (PO§ssub§4§esub§)

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - Results from a nationwide clinical audit'. Together they form a unique fingerprint.

  • Cite this